Vertex Pharmaceuticals Incorporated (VRTX) — Stock Price, Chart & Analysis
Vertex Pharmaceuticals Incorporated (VRTX) is a Healthcare stock currently trading at $514.99, up 0.84% on the day. It carries a market capitalization of $130.53B and a trailing P/E ratio of 30.01. Over the past 52 weeks, VRTX has traded between $374.17 and $560.25. Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend. View the live VRTX chart, technical opinion, analyst ratings, fundamentals and latest news below.
Vertex Pharmaceuticals Incorporated (VRTX) key data
| Price | $514.99 |
| Change (today) | +0.84% |
| Previous close | $510.72 |
| Market cap | $130.53B |
| P/E ratio (TTM) | 30.01 |
| EPS (TTM) | $17.16 |
| 52-week high | $560.25 |
| 52-week low | $374.17 |
| Beta | 0.32 |
| Avg. volume | 1.41M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Vertex Pharmaceuticals Incorporated (VRTX)
How much does one share of Vertex Pharmaceuticals Incorporated cost?
As of the latest update, one share of Vertex Pharmaceuticals Incorporated (VRTX) trades at $514.99 (+0.84% today).
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated has a market capitalization of approximately $130.53B.
What is Vertex Pharmaceuticals Incorporated's P/E ratio?
Vertex Pharmaceuticals Incorporated has a trailing price-to-earnings (P/E) ratio of 30.01.
What is Vertex Pharmaceuticals Incorporated's earnings per share (EPS)?
Vertex Pharmaceuticals Incorporated's trailing twelve-month EPS is $17.16.
Does Vertex Pharmaceuticals Incorporated pay a dividend?
Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend.
What is Vertex Pharmaceuticals Incorporated's 52-week trading range?
Over the past year, VRTX has traded between $374.17 and $560.25.
What is the analyst price target for Vertex Pharmaceuticals Incorporated?
The mean analyst price target for Vertex Pharmaceuticals Incorporated is $570.07. This is informational only and not investment advice.
Latest Vertex Pharmaceuticals Incorporated (VRTX) news
- Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies HarderNews · Sep 22, 2026
- Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on ItNews · Sep 22, 2026
- 2 Reasons to Like VRTX (and 1 Not So Much)News · Sep 18, 2026
- Is This Biotech Stock Too Cheap to Ignore After Its Latest Pullback?News · Sep 18, 2026
- Vera Reverses Its Major Chart Upset As Vertex Rivalry Deepens — What Happened?News · Sep 15, 2026
- Will Vertex’s (VRTX) New CFO Elevation and Digital Focus Reframe Its Capital Allocation Narrative?News · Sep 15, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live VRTX dashboard…